<DOC>
	<DOC>NCT01698541</DOC>
	<brief_summary>Test bioequivalence of generic tacrolimus (Tacni), using original tacrolimus (Prograf) as comparator, in elderly (&gt;60 yr) renal transplant recipients</brief_summary>
	<brief_title>Generic Tacrolimus in the Elderly - Prograf® vs Tacni®</brief_title>
	<detailed_description>12-hour pharmacokinetic investigations performed on each formulation in each patient at steady-state. Patients will be randomized with regards to which formulation to start with. 1-2 weeks between each PK investigation.</detailed_description>
	<mesh_term>Kidney Failure, Chronic</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Renal transplant recipients that will receive Tac as part of their immunosuppressive therapy. Recipients 60 years of age or older. Signed informed consent. Diabetes mellitus (WHO criteria). Concomitant treatment with: diltiazem, verapamil, phenytoin, carbamazepin, fluconazole, ketoconazole, voriconazole, erythromycin, clarithromycin.</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Renal</keyword>
	<keyword>Transplantation</keyword>
	<keyword>Elderly</keyword>
</DOC>